Volume | 9 471 472 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,4399 | Bas Haut |
|||||
Minimum Bas | 1,12 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
SELLAS Life Sciences Group Inc | SLS | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,30 | 1,12 | 1,4399 | 1,28 | 1,24 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
30 272 | 9 471 472 | US$ 1,21 | US$ 11 495 403 | - | 0,4986 - 1,914 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:51:25 | 5 | US$ 1,2597 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
40,4M | 32,06M | - | 0 | -37,34M | -1,16 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action SELLAS Life Sciences
Date | Heure | Source | Titre |
---|---|---|---|
11/3/2024 | 21:05 | Edgar (US Regulatory) | Form 8-K - Current report |
08/3/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
05/3/2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
16/2/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
25/1/2024 | 12:04 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
25/1/2024 | 12:03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
25/1/2024 | 12:02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
25/1/2024 | 12:01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
25/1/2024 | 12:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
19/1/2024 | 22:11 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
08/1/2024 | 23:07 | Edgar (US Regulatory) | Form 8-K - Current report |
05/1/2024 | 22:27 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
Forum Action SELLAS Life Sciences
Aucune Discussion TrouvéeAjouter une Discussion
Historiques SELLAS Life Sciences Group Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,61 | 1,63 | 1,12 | 1,34 | 1 537 212 | -0,35 | -21,74% |
1 mois | 1,25 | 1,72 | 1,12 | 1,40 | 1 496 223 | 0,01 | 0,80% |
3 mois | 0,679 | 1,72 | 0,65 | 1,19 | 1 456 469 | 0,581 | 85,57% |
6 mois | 0,98 | 1,72 | 0,4986 | 1,01 | 1 225 064 | 0,28 | 28,57% |
1 an | 1,40 | 1,914 | 0,4986 | 1,08 | 732 269 | -0,14 | -10,00% |
3 ans | 7,88 | 15,0789 | 0,4986 | 3,12 | 439 302 | -6,62 | -84,01% |
5 ans | 1,01 | 19,38 | 0,1021 | 1,95 | 2 397 752 | 0,25 | 24,75% |